New Delhi, February 27 Drug maker Abbott announced on Friday that it has partnered with Novo Nordisk India to commercialize Extensior, a second brand of Ozempic, for the treatment of type 2 diabetes in the country.The partnership leverages Novo Nordisk's scientific leadership in GLP-1s and...
New Delhi, February 10 Researchers are cautioning against relying solely on glycated haemoglobin, 'HbA1c', for diagnosing and monitoring diabetes in South Asia, especially India, as the high prevalence of anaemia and blood disorders can complicate the interpretation of values.In a viewpoint...